Destiny Pharma (DEST) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Apr 2024 07:00 AM
RNS
Notice of Full Year Results
19 Mar 2024 02:47 PM
RNS
Exercise of Options and Total Voting Rights
31 Jan 2024 07:00 AM
RNS
Clinical development update
22 Jan 2024 07:00 AM
RNS
Appointment of Nominated Adviser and Sole Broker
04 Jan 2024 07:00 AM
RNS
Year End Business Update
20 Oct 2023 07:00 AM
RNS
Grant of Share Options
19 Oct 2023 07:00 AM
RNS
Director/PDMR Shareholding
17 Oct 2023 07:01 AM
RNS
XF Pipeline Update Meeting
17 Oct 2023 07:00 AM
RNS
Publication of new microbiological data for XF-73
10 Oct 2023 07:00 AM
RNS
Director/PDMR Shareholding
04 Oct 2023 12:34 PM
RNS
Director/PDMR Shareholding
27 Sep 2023 07:00 AM
RNS
Notice of XF Pipeline Update Meeting
20 Sep 2023 07:00 AM
RNS
Interim Results
23 Aug 2023 07:00 AM
RNS
Notice of Interim Results
31 Jul 2023 12:01 PM
RNS
Publication of new data for XF-73
25 Jul 2023 07:00 AM
RNS
Appointment of new Chairman
19 Jul 2023 12:55 PM
RNS
Board changes including appointment of new CEO
07 Jul 2023 07:00 AM
RNS
Exercise of Options and Total Voting Rights
06 Jul 2023 07:00 AM
RNS
Positive findings from recent SAB meeting
29 Jun 2023 07:00 AM
RNS
Business Update
26 May 2023 03:27 PM
RNS
Director/PDMR Shareholding
26 May 2023 07:00 AM
RNS
Director Dealing
25 May 2023 12:23 PM
RNS
Result of Annual General Meeting
25 May 2023 07:00 AM
RNS
Dr Debra Barker Appointed Interim CEO
12 May 2023 12:24 PM
RNS
Grant of Share Options
02 May 2023 07:00 AM
RNS
Positive results from SPOR-COV® research
26 Apr 2023 04:10 PM
RNS
Posting of Annual Report and Notice of AGM
26 Apr 2023 10:05 AM
RNS
Exercise of Options and Total Voting Rights
13 Apr 2023 07:00 AM
RNS
Audited results for year ended 31 December 2022
04 Apr 2023 07:00 AM
RNS
Landmark data published on NTCD-M3
03 Apr 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
24 Mar 2023 07:00 AM
RNS
Landmark XF-73 Phase 2 data published in journal
16 Mar 2023 03:29 PM
RNS
Result of General Meeting and Total Voting Rights
15 Mar 2023 04:02 PM
RNS
Result of Open Offer
06 Mar 2023 10:50 AM
RNS
Exercise of Options and Total Voting Rights
06 Mar 2023 10:31 AM
RNS
Holding(s) in Company
28 Feb 2023 03:55 PM
RNS
Posting of Circular and Notice of General Meeting
27 Feb 2023 04:30 PM
RNS
Director/PDMR Shareholding
24 Feb 2023 01:32 PM
RNS
Issue of Equity
24 Feb 2023 01:32 PM
RNS
Agreement with Sebela Pharmaceutical for NTCD-M3
24 Feb 2023 11:00 AM
RNS
Price Monitoring Extension
31 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
26 Jan 2023 10:10 AM
RNS
Exercise of Options and Total Voting Rights
25 Jan 2023 07:00 AM
RNS
US Center for Disease Control review paper
22 Dec 2022 09:05 AM
RNS
Second Price Monitoring Extn
22 Dec 2022 09:00 AM
RNS
Price Monitoring Extension
22 Dec 2022 07:00 AM
RNS
Year End Trading Update
07 Dec 2022 07:00 AM
RNS
FDA/CDC highlight need for infection preventions
07 Dec 2022 07:00 AM
RNS
XF-73 Nasal final Phase 3 development plans
02 Dec 2022 02:48 PM
RNS
Director Disclosure
UK 100

Latest directors dealings